维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

19篇 您的检索式：作者名="Kirschfink M"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Strategies of therapeutic complement inhibition显示文摘	Mollnes T E Kirschfink M	2006	Mol Immunol2006，43，12：	1
	2	Evaluation of aortic regurgitation alter transcatheter aortic valve implantation:aortic root angiography in comparison to cardiac magnetic resonance显示文摘	Frick M Meyer CG Kirschfink A	2015	EuroIntervention2015，10，11：	1
	3	Efficacy of ecutizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome : a case report 显示文摘	Kronbichler A Frank R Kirschfink M	2014	Medicine (Baltimore)2014，93，26：	1
	4	Controlling the complement system in inflammation显示文摘	Kirschfink M	1997	Immunopharmacology1997，38，1：	1
	5	Activation of complement by cold agglntinins 显示文摘	Kirschfink M Knoblanch K Roelcke D		Infusionsther Transfusionsmed0，21，6：	1
	6	Developing medical educators-a mixed method evaluation of a teaching education program显示文摘	Roos M Kadmon M Kirschfink M	2014	Medical Education Online2014，19，10：	1
	7	Modern complement analysis显示文摘	Kirschfink M Mollnes T E	2003	Clinical and Diagnostic Laboratory Immunology2003，10，：	1
	8	Comple- ment in human diseases: Lessons from complement deficiencies 显示文摘	BOTTO M KIRSCHFINK M	2009	Molecular Immunology2009，14，46：	1
	9	Human C1 esterase inhibitor attenuates routine mesenteric ischemia/reperfusion induced local organ injury 显示文摘	Karpel-Massler G Fleming SD Kirschfink M	2003	Journal of Surgical Research2003，115，2：	1
	10	Immune response to autologous transfusion in healthy volunteers:WB versus packed RBCs and FFP显示文摘	Frietsch T Fessler H Kirschfink M	2001	Transfusion2001，41，4：	1
	11	Targeting complement in therapy显示文摘	Kirschfink M	2001	Immunol Rev2001，180，：	1
	12	Specific siRNA targeting of the membrane complement regulator CD59 with herceptin immunoli- posomes sensitize breast carcinoma ceils to complement mediated cytotoxicity 显示文摘	Mamidi S Gies N Kirschfink M	2010	Clinical Immunology2010，135，：	1
	13	Mechanism of complement activation during extracorporeal blood- biomaterial interaction;effects of heparin coated and uncoated surfaces 显示文摘	Mottaghy K Kirschfink M	2002	ASAIO Journal2002，48，：	1
	14	C1-inhibitor:an anti-inflammatory reagent with therapeutic potential显示文摘	Kirschfink M Mollnes TE	2001	Expert Opin Pharmacother2001，2，7：	1
	15	Immune response to autologous transfusion in healthy volunteers:WB versus packed RBCs and FFP显示文摘	Frietsch T Fessler H Kirschfink M	2001	Transfusion2001，41，4：	1
	16	Immunoglobulin G subclass concentrations and infections in children and adolescents with severe asthma显示文摘	de Moraes Lui C Oliveira LC Diogo CL Kirschfink M Grumach AS	2002	Pediatr Allergy Immunol2002，13，3：	1
	17	Targeting complement in therapy显示文摘	Kirschfink M	2001	Mmunological Revievs2001，180，1：	1
	18	Controlling the complement system in inflammation显示文摘	Kirschfink M	1997	Immuno pharmacology1997，38，：	1
	19	Eculizumab and refractory membranoproliferative glomerulonephritis 显示文摘	Radhakrishnan S Lunn A Kirschfink M	2012	N Engl J Med2012，366，12：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费